Results 181 to 190 of about 279,308 (307)
Metabolic bone disease in children and adolescent patients with ulcerative colitis. [PDF]
Mosli MH, Saadah OI.
europepmc +1 more source
Mesoporous Silica Nanoparticles in Biomedicine: Advances and Prospects
Mesoporous silica nanoparticles offer unique properties like high surface area, tunable pores, and functionalization. They excel in drug delivery, tissue engineering, and stimuli‐responsive therapies, enabling targeted and controlled treatments. With roles in cancer therapy and diagnostics, their clinical translation requires addressing challenges in ...
Miguel Manzano, María Vallet‐Regí
wiley +1 more source
Is quantitative ultrasound a measure for metabolic bone disease in preterm-born infants? A prospective subcohort study. [PDF]
de Lange A +2 more
europepmc +1 more source
This study presents human in vitro rheumatoid arthritis models using chondrocytes recellularized type II collagen scaffold and 3D‐bioprinted Gelatin‐Matrigel hydrogels with fibroblast‐like synoviocytes, pro‐inflammatory macrophages, and protective barrier macrophages, closely recapitulating key rheumatoid arthritis pathological features.
Huiqun Zhou +6 more
wiley +1 more source
Risk factors for metabolic bone disease among preterm infants less than 32 weeks gestation with Bronchopulmonary dysplasia. [PDF]
Chen W, Zhang Z, Dai S, Xu L.
europepmc +1 more source
A new approach to extracellular matrix‐mimetic, hierarchical biomaterials is presented. Soft gels composed of overpacked hydrogel microparticle arrays present a biomolecularly crowded environment permissive to the self‐assembly of collagen networks.
Elif Narbay +11 more
wiley +1 more source
Does metabolic control of the disease related with bone turnover markers in children with type 1 diabetes mellitus in Turkey? [PDF]
Merve Sena Topkaya +2 more
openalex +1 more source

